Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Lower Arterial Cross-Sectional Area of Carotid and Vertebral Arteries and Higher Frequency of Secondary Neck Vessels Are Associated with Multiple Sclerosis.

Belov P, Jakimovski D, Krawiecki J, Magnano C, Hagemeier J, Pelizzari L, Weinstock-Guttman B, Zivadinov R.

AJNR Am J Neuroradiol. 2018 Jan;39(1):123-130. doi: 10.3174/ajnr.A5469. Epub 2017 Dec 7.

2.

Cerebral Microbleeds in Multiple Sclerosis Evaluated on Susceptibility-weighted Images and Quantitative Susceptibility Maps: A Case-Control Study.

Zivadinov R, Ramasamy DP, Benedict RR, Polak P, Hagemeier J, Magnano C, Dwyer MG, Bergsland N, Bertolino N, Weinstock-Guttman B, Kolb C, Hojnacki D, Utriainen D, Haacke EM, Schweser F.

Radiology. 2016 Dec;281(3):884-895. Epub 2016 Jun 16.

PMID:
27308776
3.

Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients.

Beggs CB, Magnano C, Belov P, Krawiecki J, Ramasamy DP, Hagemeier J, Zivadinov R.

PLoS One. 2016 May 2;11(5):e0153960. doi: 10.1371/journal.pone.0153960. eCollection 2016.

4.

Age-related brain atrophy may be mitigated by internal jugular vein enlargement in male individuals without neurologic disease.

Belov P, Magnano C, Krawiecki J, Hagemeier J, Bergsland N, Beggs C, Zivadinov R.

Phlebology. 2017 Mar;32(2):125-134. doi: 10.1177/0268355516633610. Epub 2016 Jul 9.

PMID:
26911619
5.

Internal Jugular Vein Cross-Sectional Area Enlargement Is Associated with Aging in Healthy Individuals.

Magnano C, Belov P, Krawiecki J, Hagemeier J, Beggs C, Zivadinov R.

PLoS One. 2016 Feb 19;11(2):e0149532. doi: 10.1371/journal.pone.0149532. eCollection 2016.

6.

Dirty-Appearing White Matter in the Brain is Associated with Altered Cerebrospinal Fluid Pulsatility and Hypertension in Individuals without Neurologic Disease.

Beggs CB, Magnano C, Shepherd SJ, Belov P, Ramasamy DP, Hagemeier J, Zivadinov R.

J Neuroimaging. 2016 Jan-Feb;26(1):136-43. doi: 10.1111/jon.12249. Epub 2015 Apr 20.

PMID:
25893376
7.

Quantifying errors in flow measurement using phase contrast magnetic resonance imaging: comparison of several boundary detection methods.

Jiang J, Kokeny P, Ying W, Magnano C, Zivadinov R, Mark Haacke E.

Magn Reson Imaging. 2015 Feb;33(2):185-93. doi: 10.1016/j.mri.2014.10.009. Epub 2014 Nov 12.

8.

Aqueductal cerebrospinal fluid pulsatility in healthy individuals is affected by impaired cerebral venous outflow.

Beggs CB, Magnano C, Shepherd SJ, Marr K, Valnarov V, Hojnacki D, Bergsland N, Belov P, Grisafi S, Dwyer MG, Carl E, Weinstock-Guttman B, Zivadinov R.

J Magn Reson Imaging. 2014 Nov;40(5):1215-22. doi: 10.1002/jmri.24468. Epub 2013 Nov 8.

PMID:
24214844
9.

Improved operator agreement and efficiency using the minimum area contour change method for delineation of hyperintense multiple sclerosis lesions on FLAIR MRI.

Wack DS, Dwyer MG, Bergsland N, Ramasamy D, Di Perri C, Ranza L, Hussein S, Magnano C, Seals K, Zivadinov R.

BMC Med Imaging. 2013 Sep 3;13:29. doi: 10.1186/1471-2342-13-29.

10.

Effect of age on MRI phase behavior in the subcortical deep gray matter of healthy individuals.

Hagemeier J, Dwyer MG, Bergsland N, Schweser F, Magnano CR, Heininen-Brown M, Ramasamy DP, Carl E, Kennedy C, Melia R, Polak P, Deistung A, Geurts JJ, Reichenbach JR, Zivadinov R.

AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2144-51. doi: 10.3174/ajnr.A3569. Epub 2013 May 30.

11.

Changes of cine cerebrospinal fluid dynamics in patients with multiple sclerosis treated with percutaneous transluminal angioplasty: a case-control study.

Zivadinov R, Magnano C, Galeotti R, Schirda C, Menegatti E, Weinstock-Guttman B, Marr K, Bartolomei I, Hagemeier J, Malagoni AM, Hojnacki D, Kennedy C, Carl E, Beggs C, Salvi F, Zamboni P.

J Vasc Interv Radiol. 2013 Jun;24(6):829-38. doi: 10.1016/j.jvir.2013.01.490. Epub 2013 Mar 21.

PMID:
23523158
12.

Gray matter SWI-filtered phase and atrophy are linked to disability in MS.

Hagemeier J, Weinstock-Guttman B, Heininen-Brown M, Poloni GU, Bergsland N, Schirda C, Magnano CR, Kennedy C, Carl E, Dwyer MG, Minagar A, Zivadinov R.

Front Biosci (Elite Ed). 2013 Jan 1;5:525-32.

PMID:
23277008
13.

Functional anatomy of the masking level difference, an fMRI study.

Wack DS, Cox JL, Schirda CV, Magnano CR, Sussman JE, Henderson D, Burkard RF.

PLoS One. 2012;7(7):e41263. doi: 10.1371/journal.pone.0041263. Epub 2012 Jul 27.

14.

Cine cerebrospinal fluid imaging in multiple sclerosis.

Magnano C, Schirda C, Weinstock-Guttman B, Wack DS, Lindzen E, Hojnacki D, Bergsland N, Kennedy C, Belov P, Dwyer MG, Poloni GU, Beggs CB, Zivadinov R.

J Magn Reson Imaging. 2012 Oct;36(4):825-34. doi: 10.1002/jmri.23730. Epub 2012 Jun 25.

PMID:
22733409
15.

Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis.

Beggs CB, Shepherd SJ, Dwyer MG, Polak P, Magnano C, Carl E, Poloni GU, Weinstock-Guttman B, Zivadinov R.

Neurol Res. 2012 Oct;34(8):793-801. doi: 10.1179/1743132812Y.0000000048. Epub 2012 Jun 16.

PMID:
22709857
16.

Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy.

Hagemeier J, Weinstock-Guttman B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Magnano C, Hojnacki D, Dwyer MG, Zivadinov R.

AJNR Am J Neuroradiol. 2012 Sep;33(8):1596-601. doi: 10.3174/ajnr.A3030. Epub 2012 Mar 29.

17.

Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: a case control study.

Hagemeier J, Heininen-Brown M, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Weinstock-Guttman B, Dwyer MG, Zivadinov R.

J Magn Reson Imaging. 2012 Jul;36(1):73-83. doi: 10.1002/jmri.23603. Epub 2012 Mar 7.

PMID:
22407571
18.

3D FLAIRED: 3D fluid attenuated inversion recovery for enhanced detection of lesions in multiple sclerosis.

Polak P, Magnano C, Zivadinov R, Poloni G.

Magn Reson Med. 2012 Sep;68(3):874-81. doi: 10.1002/mrm.23289. Epub 2011 Dec 2.

19.

Assessing abnormal iron content in the deep gray matter of patients with multiple sclerosis versus healthy controls.

Habib CA, Liu M, Bawany N, Garbern J, Krumbein I, Mentzel HJ, Reichenbach J, Magnano C, Zivadinov R, Haacke EM.

AJNR Am J Neuroradiol. 2012 Feb;33(2):252-8. doi: 10.3174/ajnr.A2773. Epub 2011 Nov 24.

20.

Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency.

Zivadinov R, Poloni GU, Marr K, Schirda CV, Magnano CR, Carl E, Bergsland N, Hojnacki D, Kennedy C, Beggs CB, Dwyer MG, Weinstock-Guttman B.

BMC Neurol. 2011 Oct 19;11:128. doi: 10.1186/1471-2377-11-128.

21.

Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study.

Zivadinov R, Heininen-Brown M, Schirda CV, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Hagemeier J, Benedict RH, Weinstock-Guttman B, Dwyer MG.

Neuroimage. 2012 Jan 2;59(1):331-9. doi: 10.1016/j.neuroimage.2011.07.045. Epub 2011 Jul 27.

PMID:
21820063
22.

Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients.

Pantalone GR, Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Romeo MA, Magnano C, Caruso V, Argento C, Gerardi C, Campisi S, Violi P, Malizia R, Cianciulli P, Rizzo M, D'Ascola DG, Quota A, Prossomariti L, Fidone C, Rigano P, Pepe A, D'Amico G, Morabito A, Gluud C.

Hemoglobin. 2011;35(3):206-16. doi: 10.3109/03630269.2011.570674.

PMID:
21599433
23.

Value of MR venography for detection of internal jugular vein anomalies in multiple sclerosis: a pilot longitudinal study.

Zivadinov R, Galeotti R, Hojnacki D, Menegatti E, Dwyer MG, Schirda C, Malagoni AM, Marr K, Kennedy C, Bartolomei I, Magnano C, Salvi F, Weinstock-Guttman B, Zamboni P.

AJNR Am J Neuroradiol. 2011 May;32(5):938-46. doi: 10.3174/ajnr.A2386. Epub 2011 Apr 7.

24.

Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report.

Zamboni P, Menegatti E, Weinstock-Guttman B, Dwyer MG, Schirda CV, Malagoni AM, Hojnacki D, Kennedy C, Carl E, Bergsland N, Magnano C, Bartolomei I, Salvi F, Zivadinov R.

BMC Med. 2011 Mar 7;9:22. doi: 10.1186/1741-7015-9-22.

25.

Use of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects.

Zivadinov R, Lopez-Soriano A, Weinstock-Guttman B, Schirda CV, Magnano CR, Dolic K, Kennedy CL, Brooks CL, Reuther JA, Hunt K, Andrews M, Dwyer MG, Hojnacki DW.

Radiology. 2011 Feb;258(2):562-70. doi: 10.1148/radiol.10101387. Epub 2010 Dec 21.

PMID:
21177394
26.

Genotype-phenotype relationship of the δ-thalassemia and Hb A(2) variants: observation of 52 genotypes.

Lacerra G, Scarano C, Lagona LF, Testa R, Caruso DG, Medulla E, Friscia MG, Mastrullo L, Caldora M, Prezioso R, Gaudiano C, Magnano C, Romeo MA, Musollino G, Di Noce F, Carestia C.

Hemoglobin. 2010;34(5):407-23. doi: 10.3109/03630269.2010.511586.

PMID:
20854114
27.

Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study.

Zivadinov R, Schirda C, Dwyer MG, Haacke ME, Weinstock-Guttman B, Menegatti E, Heininen-Brown M, Magnano C, Malagoni AM, Wack DS, Hojnacki D, Kennedy C, Carl E, Bergsland N, Hussein S, Poloni G, Bartolomei I, Salvi F, Zamboni P.

Int Angiol. 2010 Apr;29(2):158-75.

PMID:
20351672
28.

Use of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls.

Hojnacki D, Zamboni P, Lopez-Soriano A, Galleotti R, Menegatti E, Weinstock-Guttman B, Schirda C, Magnano C, Malagoni AM, Kennedy C, Bartolomei I, Salvi F, Zivadinov R.

Int Angiol. 2010 Apr;29(2):127-39.

PMID:
20351669
29.

Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial.

Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Romeo MA, Magnano C, Caruso V, Argento C, Gerardi C, Campisi S, Violi P, Malizia R, Cianciulli P, Rizzo M, D'Ascola DG, Quota A, Prossomariti L, Fidone C, Rigano P, Pepe A, D'Amico G, Morabito A, Gluud C.

Br J Haematol. 2009 Apr;145(2):245-54. doi: 10.1111/j.1365-2141.2009.07609.x. Epub 2009 Feb 19.

PMID:
19236376
30.

Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.

Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Magnano C, Rizzo M, Caruso V, Gerardi C, Argento C, Campisi S, Cantella F, Commendatore F, D'Ascola DG, Fidone C, Ciancio A, Galati MC, Giuffrida G, Cingari R, Giugno G, Lombardo T, Prossomariti L, Malizia R, Meo A, Roccamo G, Romeo MA, Violi P, Cianciulli P, Rigano P.

Blood Cells Mol Dis. 2009 May-Jun;42(3):247-51. doi: 10.1016/j.bcmd.2009.01.002. Epub 2009 Feb 23.

PMID:
19233692
31.

Molecular evidences of single mutational events followed by recurrent crossing-overs in the common delta-globin alleles in the Mediterranean area.

Lacerra G, Musollino G, Scarano C, Lagona LF, Caruso DG, Testa R, Prezioso R, Di Noce F, Medulla E, Friscia MG, Mastrullo L, Caldora M, Nota L, Gaudiano C, Magnano C, Ciaccio C, Romeo MA, Carestia C.

Gene. 2008 Feb 29;410(1):129-38. doi: 10.1016/j.gene.2007.12.004. Epub 2007 Dec 14.

PMID:
18221842
32.

Risk factors for death in patients with beta-thalassemia major: results of a case-control study.

Ceci A, Baiardi P, Catapano M, Felisi M, Cianciulli P, De Sanctis V, Del Vecchio GC, Magnano C, Meo A, Maggio A.

Haematologica. 2006 Oct;91(10):1420-1. Epub 2006 Sep 7.

33.

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.

Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, Aydinok Y, Kattamis A, Kilinc Y, Porter J, Capra M, Galanello R, Fattoum S, Drelichman G, Magnano C, Verissimo M, Athanassiou-Metaxa M, Giardina P, Kourakli-Symeonidis A, Janka-Schaub G, Coates T, Vermylen C, Olivieri N, Thuret I, Opitz H, Ressayre-Djaffer C, Marks P, Alberti D.

Blood. 2006 May 1;107(9):3455-62. Epub 2005 Dec 13.

34.

Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.

Grosse R, Lund U, Caruso V, Fischer R, Janka GE, Magnano C, Engelhardt R, Dürken M, Nielsen P.

Ann N Y Acad Sci. 2005;1054:429-32.

PMID:
16339692
35.

Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies.

Derchi G, Forni GL, Formisano F, Cappellini MD, Galanello R, D'Ascola G, Bina P, Magnano C, Lamagna M.

Haematologica. 2005 Apr;90(4):452-8.

36.

Computed tomographic perfusion in the management of aneurysmal subarachnoid hemorrhage: new application of an existent technique.

Harrigan MR, Magnano CR, Guterman LR, Hopkins LN.

Neurosurgery. 2005 Feb;56(2):304-17; discussion 304-17. Review.

PMID:
15670379
37.

Clinical and histological characterization of liver disease in patients with transfusion-dependent beta-thalassemia. A multicenter study of 117 cases.

Prati D, Maggioni M, Milani S, Cerino M, Cianciulli P, Coggi G, Forni GL, Magnano C, Meo A, Gramignoli R, Rebulla P, Fiorelli G, Cappellini MD; Cooleycare Cooperative Group.

Haematologica. 2004 Oct;89(10):1179-86.

38.

Preclinical thalassemic cardiopathy: a study by acoustic densitometry.

Di Paola R, Di Guardo G, Lo Giudice P, Caruso V, Magnano C, Mangiameli S.

Ital Heart J. 2003 Jun;4(6):413-8.

PMID:
12898807
39.

Potential myocardial iron content evaluation by magnetic resonance imaging in thalassemia major patients treated with Deferoxamine or Deferiprone during a randomized multicenter prospective clinical study.

Galia M, Midiri M, Bartolotta V, Morabito A, Rizzo M, Mangiagli A, Malizia R, Borsellino Z, Capra M, D'Ascola DG, Magnano C, Gerardi C, Rigano P, Maggio A; Multicenter Trial Group of the Society for the Study of Thalassemia and Haemoglobinopathies.

Hemoglobin. 2003 May;27(2):63-76.

PMID:
12779268
40.

Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial.

Maggio A, D'Amico G, Morabito A, Capra M, Ciaccio C, Cianciulli P, Di Gregorio F, Garozzo G, Malizia R, Magnano C, Mangiagli A, Quarta G, Rizzo M, D'Ascola DG, Rizzo A, Midiri M.

Blood Cells Mol Dis. 2002 Mar-Apr;28(2):196-208.

PMID:
12064916
41.

Hb G-San Josè variant levels correlate with alpha-thalassemia genotypes.

Lacerra G, Fiorito M, Pagano L, Testa R, Li Volti G, Magnano C, Medulla E, Caresti C.

Hemoglobin. 2002 Feb;26(1):59-66.

PMID:
11939513
42.

Thrombophilia in thalassemia major patients: analysis of genetic predisposing factors.

Iolascon A, Giordano P, Storelli S, Li HH, Coppola B, Piga A, Fantola E, Forni G, Cianciulli P, Perrotta S, Magnano C, Maggio A, Mangiagli A, Devoto M.

Haematologica. 2001 Oct;86(10):1112-3. No abstract available.

43.

Origin and spread of Hb G-San Josè in Southern Italy.

Lacerra G, De Angioletti M, Pagano L, Magnano C, Medulla E, Carestia C.

Haematologica. 2001 Oct;86(10):1097-8. No abstract available.

44.

The incidence and natural course of transfusion-associated GB virus C/hepatitis G virus infection in a cohort of thalassemic patients. The Cooleycare Cooperative Group.

Prati D, Zanella A, Bosoni P, Rebulla P, Farma E, De Mattei C, Capelli C, Mozzi F, Gallisai D, Magnano C, Melevendi C, Sirchia G.

Blood. 1998 Feb 1;91(3):774-7.

45.

Differences in salivary cortisol levels in cocaine-exposed and noncocaine-exposed NICU infants.

Magnano CL, Gardner JM, Karmel BZ.

Dev Psychobiol. 1992 Mar;25(2):93-103.

PMID:
1577206
46.

[Radiology of thalassemic syndrome in the transition from the old to the new therapeutic transfusion regimen].

De Luca B, Magnano C, Caruso V, Blandini S, Massimino R, Majorana M.

Pediatr Med Chir. 1991 Sep-Oct;13(5):481-7. Italian.

PMID:
1788109
47.

[The endocrine complications in thalassemia major].

Anastasi S, Caruso V, Magnano C, Leocata A.

Pediatr Med Chir. 1991 Jan-Feb;13(1):63-5. Review. Italian.

PMID:
2052458
48.

Neurofunctional consequences of in utero cocaine exposure.

Karmel BZ, Gardner JM, Magnano CL.

NIDA Res Monogr. 1990;105:535-6. No abstract available.

PMID:
1876110
49.

Use of salivary cortisol measurements in young infants: a note of caution.

Magnano CL, Diamond EJ, Gardner JM.

Child Dev. 1989 Oct;60(5):1099-101.

PMID:
2805888
50.

Brain-stem auditory evoked responses as indicators of early brain insult.

Karmel BZ, Gardner JM, Zappulla RA, Magnano CL, Brown EG.

Electroencephalogr Clin Neurophysiol. 1988 Nov-Dec;71(6):429-42.

PMID:
2460324

Supplemental Content

Loading ...
Support Center